Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 3
2008 1
2009 1
2011 2
2012 5
2013 4
2014 5
2015 3
2016 3
2017 2
2018 3
2019 3
2020 3
2021 2
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW. Pozdeyev N, et al. Among authors: labarbera dv. Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3. Clin Cancer Res. 2018. PMID: 29615459 Free PMC article.
High-throughput imaging: Focusing in on drug discovery in 3D.
Li L, Zhou Q, Voss TC, Quick KL, LaBarbera DV. Li L, et al. Among authors: labarbera dv. Methods. 2016 Mar 1;96:97-102. doi: 10.1016/j.ymeth.2015.11.013. Epub 2015 Nov 21. Methods. 2016. PMID: 26608110 Free PMC article. Review.
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.
Rinaldetti S, Zhou Q, Abbott JM, de Jong FC, Esquer H, Costello JC, Theodorescu D, LaBarbera DV. Rinaldetti S, et al. Among authors: labarbera dv. Int J Mol Sci. 2022 Sep 14;23(18):10605. doi: 10.3390/ijms231810605. Int J Mol Sci. 2022. PMID: 36142576 Free PMC article.
HTS discovery of PARP1-HPF1 complex inhibitors in cancer.
Kellett T, Noor R, Zhou Q, Esquer H, Sala R, Stojanovic P, Rudolph J, Luger K, LaBarbera DV. Kellett T, et al. Among authors: labarbera dv. SLAS Discov. 2023 Dec;28(8):394-401. doi: 10.1016/j.slasd.2023.10.003. Epub 2023 Oct 14. SLAS Discov. 2023. PMID: 37844763 Free PMC article.
Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.
Prigaro BJ, Esquer H, Zhou Q, Pike LA, Awolade P, Lai XH, Abraham AD, Abbott JM, Matter B, Kompella UB, Messersmith WA, Gustafson DL, LaBarbera DV. Prigaro BJ, et al. Among authors: labarbera dv. J Med Chem. 2022 Mar 10;65(5):3943-3961. doi: 10.1021/acs.jmedchem.1c01778. Epub 2022 Feb 22. J Med Chem. 2022. PMID: 35192363 Free PMC article.
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.
Agarwal N, Zhou Q, Arya D, Rinaldetti S, Duex J, LaBarbera DV, Theodorescu D. Agarwal N, et al. Among authors: labarbera dv. Int J Mol Sci. 2022 Sep 16;23(18):10819. doi: 10.3390/ijms231810819. Int J Mol Sci. 2022. PMID: 36142729 Free PMC article.
43 results